CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,107 | $569.01 | $630K | 23,685 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,405 | $570.05 | $1.4M | 21,280 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,755 | $571.10 | $1.0M | 19,525 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −649 | $571.92 | $371K | 18,876 |
| 2026-04-27 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 52,500 | ||
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,502 | $565.75 | $850K | 48,511 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,311 | $566.56 | $743K | 47,200 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,023 | $567.61 | $581K | 46,177 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −583 | $568.58 | $331K | 45,594 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,891 | $569.75 | $1.1M | 43,703 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,653 | $570.57 | $943K | 42,050 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,417 | $571.49 | $810K | 40,633 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $572.22 | $69K | 40,513 |
| 2026-04-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 110,288 | ||
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $561.21 | $180K | 49,693 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −878 | $562.37 | $494K | 48,815 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,316 | $563.49 | $742K | 47,499 |
| 2026-04-24 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,796 | $564.53 | $1.0M | 45,703 |
Page 116 of 121 · 2,404 trades